Asterias raises $12.5M

In a private transaction, BioTime (BTX -0.3%) subsidiary Asterias Biotherapeutics raises $12.5M through the sale of 5M BTX shares of common stock held by Asterias and the issuance of warrants to purchase 5M shares of Asterias Series B common stock. The BTX shares were sold at $2.50/share. The warrants' exercise price is $2.34. If they are exercised in full, Asterias will receive an additional $11.7M.

Proceeds will be used to finance Asterias' product development programs including AST-OPC1 for the treatment of spinal cord injury and AST-VAC2, an immunotherapeutic for non-small cell lung cancer.

Comments (1)
  • jollylou
    , contributor
    Comments (2) | Send Message
    When do I get the opportunity as a BTX shareholder to purchase warrants @2.34. ????
    17 Jun 2014, 01:19 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs